Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
暂无分享,去创建一个
Ian A. Donaldson | H. Ahmed | C. Moore | M. Emberton | A. Miners | J. H. van der Meulen | I. Donaldson | S. Willis
[1] M. Cowie. National Institute for Health and Care Excellence. , 2015, European heart journal.
[2] Maarten de Rooij,et al. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. , 2014, European urology.
[3] M. Stifelman,et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.
[4] F. Schröder,et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.
[5] Jurgen J Fütterer,et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.
[6] H. Ahmed,et al. Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies , 2014, Current Urology Reports.
[7] L. Lipshultz,et al. Re: A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging-Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial , 2014 .
[8] T. H. van der Kwast,et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.
[9] Baris Turkbey,et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.
[10] M. Emberton. Has magnetic resonance-guided biopsy of the prostate become the standard of care? , 2013, European urology.
[11] Heinz-Peter Schlemmer,et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. , 2013, The Journal of urology.
[12] J. Fütterer,et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.
[13] C Fraser,et al. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. , 2013, Health technology assessment.
[14] H. Ahmed,et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. , 2013, The Journal of urology.
[15] Mark Emberton,et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.
[16] D. Hawkes,et al. The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. , 2012, The Journal of urology.
[17] B. K. Park,et al. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. , 2011, AJR. American journal of roentgenology.
[18] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[19] Yipeng Hu,et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.
[20] A. D'Amico,et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.
[21] Laura Esserman,et al. Rethinking screening for breast cancer and prostate cancer. , 2009, JAMA.
[22] Theodore L. DeWeese,et al. Localized Prostate Cancer , 2007 .
[23] Susanne Hempel,et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.
[24] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[25] David Moher,et al. The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].
[26] F. Khan,et al. TRANSRECTAL ULTRASOUND GUIDED BIOPSY OF THE PROSTATE , 1998 .
[27] M W Kattan,et al. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. , 1996, The Journal of urology.
[28] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[29] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.